Science Explorer Interactive view Map
Topic · Surgery

Pediatric Hepatobiliary Diseases and Treatments

Pediatric Hepatobiliary Diseases and Treatments is a research topic within Surgery. Science Explorer counts 33k research works in it since 1950. 11.7% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathogenesis, diagnosis, management, and outcomes of biliary atresia, including related conditions such as Alagille syndrome and choledochal cysts. It covers topics such as the Kasai operation, liver transplantation, inflammation, and the etiology of these conditions.

  • Biliary Atresia
  • Alagille Syndrome
  • Kasai Operation
  • Cholestasis
  • Hepaticojejunostomy
  • Choledochal Cysts
  • Liver Transplantation
  • Inflammation
  • Pancreaticobiliary Maljunction
  • Etiology
Research works
33k
fractional, since 1950
In the world top 10%
3.9k
per year above
Top-10% rate
11.7%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+22%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Pediatric Hepatobiliary Diseases and Treatments research?

By volume, the United States and China publish the most (869 and 740 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 869 works
  2. 2 China 740 works
  3. 3 Japan 456 works
  4. 4 India 432 works
  5. 5 United Kingdom 198 works
  6. 6 Italy 172 works
  7. 7 Germany 143 works
  8. 8 Spain 127 works
  9. 9 South Korea 126 works
  10. 10 Türkiye 122 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 25.7%China: 21.8%Japan: 13.5%India: 12.8%6 others listed: 26.2%26%largest
United States869 · 25.7%China740 · 21.8%Japan456 · 13.5%India432 · 12.8%6 others listed889 · 26.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Pediatric Hepatobiliary Diseases and Treatments research?

By volume in 2022–2025, Post Graduate Institute of Medical Education and Research publishes the most Pediatric Hepatobiliary Diseases and Treatments research, followed by King's College Hospital and Sağlık Bilimleri Üniversitesi.

By volume, 2022–2025

  1. 1 Post Graduate Institute of Medical Education and ResearchIndia 22 works
  2. 2 King's College HospitalUnited Kingdom 15 works
  3. 3 Sağlık Bilimleri ÜniversitesiTürkiye 15 works
  4. 4 Airlangga UniversityIndonesia 15 works
  5. 5 All India Institute of Medical SciencesIndia 14 works
  6. 6 Sichuan UniversityChina 14 works
  7. 7 Nagoya UniversityJapan 13 works
  8. 8 Tokyo Medical UniversityJapan 12 works
  9. 9 Mohammed V UniversityMorocco 12 works
  10. 10 Cairo UniversityEgypt 12 works

Where is Pediatric Hepatobiliary Diseases and Treatments research done?

The largest centres of Pediatric Hepatobiliary Diseases and Treatments research in 2022–2025 are Tokyo (Japan), Beijing (China), Shanghai (China) and Seoul (South Korea).

Largest cities, 2022–2025

  1. 1 Tokyo Japan 92 works
  2. 2 Beijing China 85 works
  3. 3 Shanghai China 71 works
  4. 4 Seoul South Korea 60 works
  5. 5 London United Kingdom 59 works
  6. 6 Guangzhou China 49 works
  7. 7 Moscow Russia 48 works
  8. 8 New Delhi India 47 works
  9. 9 Mexico City Mexico 44 works
  10. 10 Chengdu China 41 works
See Pediatric Hepatobiliary Diseases and Treatments on the map

Where is the best place to study Pediatric Hepatobiliary Diseases and Treatments?

Among universities, judged by research, Juntendo University, Post Graduate Institute of Medical Education and Research and Medizinische Hochschule Hannover score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 14.53%fractional works in this node (log) →share in the world top 10% →Juntendo University: 11, 20.2%Post Graduate Institute of Medical Education and Research: 22, 6.1%Medizinische Hochschule Hannover: 11, 11.3%Tokyo Medical University: 12, 7.9%Sichuan University: 14, 24.8%Shanghai Jiao Tong University: 8, 30.7%Cairo University: 12, 9.7%Aichi Medical University: 10, 8.2%Baylor College of Medicine: 9, 17.7%Osaka University of Pharmaceutical Sciences: 10, 8.7%Juntendo UniversityMedizinische Hochsch…Tokyo Medical Univer…Post Graduate Instit…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Juntendo UniversityJapan 62.620.2%14.9×11 +86.9%
2 Post Graduate Institute of Medical Education and ResearchIndia 57.16.1%14.1×22 +45.2%
3 Medizinische Hochschule HannoverGermany 56.011.3%10.3×11 +96.1%
4 Tokyo Medical UniversityJapan 47.17.9%39.1×12 +19.3%
5 Sichuan UniversityChina 46.824.8%1.7×14 +63.5%
6 Shanghai Jiao Tong UniversityChina 45.830.7%0.8×8 +138.8%
7 Cairo UniversityEgypt 45.59.7%3.2×12 +273.8%
8 Aichi Medical UniversityJapan 44.38.2%51.9×10 —
9 Baylor College of MedicineUnited States 44.217.7%4.9×9 +97.8%
10 Osaka University of Pharmaceutical SciencesJapan 43.68.7%34.6×10 —

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Pediatric Hepatobiliary Diseases and Treatments research growing?

Output in 2018–2022 was 22% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Pediatric Hepatobiliary Diseases and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.